These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease. Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018 [TBL] [Abstract][Full Text] [Related]
16. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Goetz R; Nakada Y; Hu MC; Kurosu H; Wang L; Nakatani T; Shi M; Eliseenkova AV; Razzaque MS; Moe OW; Kuro-o M; Mohammadi M Proc Natl Acad Sci U S A; 2010 Jan; 107(1):407-12. PubMed ID: 19966287 [TBL] [Abstract][Full Text] [Related]
17. Effect of Continuous Intravenous Calcium Loading on Fibroblast Growth Factor 23 in Normal and Uremic Rats. Shikida Y; Mizobuchi M; Inoue T; Hamada T; Ogata H; Koiwa F; Shibata T Calcif Tissue Int; 2018 Oct; 103(4):455-464. PubMed ID: 29882057 [TBL] [Abstract][Full Text] [Related]
18. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Urakawa I; Yamazaki Y; Shimada T; Iijima K; Hasegawa H; Okawa K; Fujita T; Fukumoto S; Yamashita T Nature; 2006 Dec; 444(7120):770-4. PubMed ID: 17086194 [TBL] [Abstract][Full Text] [Related]
19. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Gattineni J; Bates C; Twombley K; Dwarakanath V; Robinson ML; Goetz R; Mohammadi M; Baum M Am J Physiol Renal Physiol; 2009 Aug; 297(2):F282-91. PubMed ID: 19515808 [TBL] [Abstract][Full Text] [Related]
20. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis. Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]